Trial participants need to be more representative of patients
AUTOR(ES)
Roehr, Bob
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2287247Documentos Relacionados
- We need to be more pragmatic
- Studies of environmental causes of disease need to be more rigorous, leading scientists say
- The PROGRESS trial three years later: All aspects of secondary prevention after stroke need to be improved
- Email consultations in health care: Patients need to be given a choice
- Informing participants of allocation to placebo at trial closure: postal survey